Delayed-response deficit induced by local injection of the α2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys
Abstract
Two young adult monkeys (Macaca mullata) were trained to perform a delayed-response task that required the monkeys to remember a cued spatial position (left or right) over a delay interval and then to make a response to the cued position. Local injection of the alpha 2-adrenergic antagonist yohimbine (10 micrograms in 2 microliters saline) into the dorsolateral prefrontal cortex (Walker's area 46 and area 9) impaired the performance of the delayed-response task, and it was without effect on the performance of the task if there was no delay between the cue and choice signals. The main performing error after injection of yohimbine was that the monkeys responded to uncued position with higher rate. Local injection of the alpha 1-adrenergic antagonist prazosin (10 microgram in 2 microliters saline) or the beta-adrenergic antagonist propranolol (10 micrograms in 2 microliters saline) into the same cortical areas induced no significant effect on the performance of the task. The present study suggests that prefrontal alpha 2-adrenoceptors play an important role in the spatial working memory in young adult monkeys.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Studies in animals indicate that norepinephrine engages predominantly α2-receptors in the PFC when the subject is alert and interested, while actions at α1-receptors and possibly β-receptors are predominant under stressful conditions.
“Studies in animals indicate that NE engages predominantly α2-receptors in the PFC when the subject is alert and interested (Li and Mei, 1994), while actions at α1-receptors and possibly β-receptors are predominant under stressful conditions (Birnbaum et al., 2004; Ramos et al., 2005).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Li and Mei, 1994
Blockade of α2A-receptors in the monkey PFC with local yohimbine infusions markedly impairs PFC regulation of attention and behavior, inducing poor impulse control and locomotor hyperactivity.
“Blockade of α2A-receptors in the monkey PFC with local yohimbine infusions markedly impairs PFC regulation of attention and behavior, inducing poor impulse control and locomotor hyperactivity (Li and Mei, 1994; Ma et al., 2005; Ma et al., 2003).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Li and Mei, 1994
Yohimbine blockade of α2-receptors in the PFC recreates the symptoms of ADHD: inducing locomotor hyperactivity, poor impulse control, and weaker working memory.
“Conversely, yohimbine blockade of α2-receptors in the PFC recreates the symptoms of ADHD: inducing locomotor hyperactivity (Ma et al., 2005), poor impulse control (Ma et al., 2003), and weaker working memory (Li and Mei, 1994).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Li and Mei, 1994
Depletion of noradrenaline or blockade of α2A-receptors in the prefrontal cortex impairs working memory, whereas stimulation of postsynaptic α2A-receptors in the prefrontal cortex improves working memory performance.
“Thus, either depletion of noradrenaline52 or blockade of α2A-receptors in the PFC53 impairs working memory, whereas stimulation of postsynaptic α2A-receptors in the PFC improves working memory performance52,56–58.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [53]
Levels of noradrenaline released during alert, non-stressed waking optimize working memory by engaging α2A-receptors, whereas high levels released during stress impair prefrontal cortex function by stimulating lower-affinity α1-receptors and β1-receptors.
“As shown in FIG. 2, the levels of noradrenaline that are released during alert, non-stressed waking optimize working memory by engaging α2A-receptors52,53, whereas the high levels of noradrenaline that are released during stress impair PFC function by stimulating lower-affinity α1-receptors54 and β1-receptors55.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [53]
Depletion of norepinephrine or blockade of α2A receptors in PFC impairs working memory performance in monkeys.
“Either depletion of NE (35) or blockade of α2A receptors in PFC (36) impairs working memory performance in monkeys, suggesting that endogenous NE plays a large role in strengthening working memory performance.”
From Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks (2011) · cites this paper as [36]
Moderate levels of norepinephrine released during alert, nonstressed waking improve working memory performance by engaging postsynaptic α2A receptors, whereas high levels of norepinephrine released during stress impair PFC function via stimulation of lower affinity α1 and β1 receptors.
“Data from studies of monkey dorsolateral PFC demonstrate an inverted-U dose-response: moderate levels of NE released during alert, nonstressed waking improve working memory performance by engaging postsynaptic, α2A receptors (35,36), whereas high levels of NE released during stress impair PFC function via stimulation of lower affinity α1 (37) and β1 receptors (38).”
From Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks (2011) · cites this paper as [36]
Infusion of α2-AR antagonist yohimbine into monkey dlPFC impaired working memory, impulse control and locomotor activity, producing an 'ADHD-like' phenotype.
“Conversely, infusion of the α2-AR antagonist, yohimbine, into the monkey dlPFC impaired working memory (Li & Mei, 1994), impulse control (Ma, Qi, Peng, & Li, 2003) and regulation of locomotor activity (Ma, Arnsten, & Li, 2005), producing an “ADHD-like” phenotype.”
From Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species (2020) · cites this paper as Li & Mei, 1994
Cites
Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex
Funahashi, S., Bruce, C. J., & Goldman-Rakic, P. S. (1989) · Journal of Neurophysiology · doi:10.1152/jn.1989.61.2.331 · Cited by 2,685 · see citing works
Circuitry of Primate Prefrontal Cortex and Regulation of Behavior by Representational Memory
Goldman‐Rakic, P. S. (1987) · Comprehensive Physiology · doi:10.1002/cphy.cp010509 · Cited by 1,960 · see citing works
Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey
Brozoski, T. J., Brown, R. M., Rosvold, H. E., & Goldman, P. S. (1979) · Science · doi:10.1126/science.112679 · Cited by 1,500 · see citing works
A cytoarchitectural study of the prefrontal area of the macaque monkey
Walker, A. E. (1940) · The Journal of Comparative Neurology · doi:10.1002/cne.900730106 · Cited by 803 · see citing works
Arnsten, A. F. T., & Goldman-Rakic, P. S. (1985) · Science · doi:10.1126/science.2999977 · Cited by 549 · see citing works
Arnsten, A., Cai, J., & Goldman-Rakic, P. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-11-04287.1988 · Cited by 391 · see citing works
Aging in the Rhesus Monkey: Debilitating Effects on Short-term Memory
Bartus, R. T., Fleming, D., & Johnson, H. R. (1978) · Journal of Gerontology · doi:10.1093/geronj/33.6.858 · Cited by 284 · see citing works
Boyajian, C. L., Loughlin, S. E., & Leslie, F. M. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00203-4 · Cited by 185 · see citing works
Sawaguchi, T., Matsumura, M., & Kubota, K. (1990) · Journal of Neurophysiology · doi:10.1152/jn.1990.63.6.1385 · Cited by 169 · see citing works
Boyajian, C. L., & Leslie, F. M. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00190-9 · Cited by 138 · see citing works
Behavioral electrophysiology of the prefrontal cortex
Fuster, J. M. (1984) · Trends in Neurosciences · doi:10.1016/s0166-2236(84)80144-7 · Cited by 126 · see citing works
[3H]RX 781094: A new antagonist ligand labels α2-adrenoceptors in the rat brain cortex
Pimoule, C., Scatton, B., & Langer, S. Z. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90269-8 · Cited by 64 · see citing works
Summers, R. J., Jarrott, B., & Louis, W. J. (1981) · Neuroscience Letters · doi:10.1016/0304-3940(81)90096-3 · Cited by 13 · see citing works
Flagged first, then by citations
2 of the 15 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Stress signalling pathways that impair prefrontal cortex structure and function
Arnsten, A. F. T. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2648 · Cited by 3,299 · see citing works
Berridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529 · see citing works
The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation
Robbins, T. W., & Arnsten, A. F. T. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135535 · Cited by 957 · see citing works
Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948 · see citing works
Self-citationKeefe, R. S. E., Silva, S. G., Perkins, D. O., & Lieberman, J. A. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033374 · Cited by 690 · see citing works
Wang, M., Ramos, B. P., Paspalas, C. D., Shu, Y., Simen, A., Duque, A., Vijayraghavan, S., Brennan, A., Dudley, A., Nou, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.015 · Cited by 672 · see citing works
Catecholamine modulation of prefrontal cortical cognitive function
Arnsten, A. F. T. (1998) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(98)01240-6 · Cited by 608 · see citing works
Adrenergic pharmacology and cognition: Focus on the prefrontal cortex
Ramos, B. P., & Arnsten, A. F. T. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.006 · Cited by 641 · see citing works
Arnsten, A. F. T., Wang, M. J., & Paspalas, C. D. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.038 · Cited by 538 · see citing works
Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning
Lesh, T. A., Niendam, T. A., Minzenberg, M., & Carter, C. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.156 · Cited by 495 · see citing works
Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks
Arnsten, A. F. T. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.027 · Cited by 493 · see citing works
Catecholamine regulation of the prefrontal cortex
Arnsten, A. F. T. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100208 · Cited by 489 · see citing works
Logue, S. F., & Gould, T. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.08.007 · Cited by 477 · see citing works
Stimulants: Therapeutic Actions in ADHD
Arnsten, A. F. T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301164 · Cited by 473 · see citing works
Arnsten, A. F. T. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050084013 · Cited by 458 · see citing works
Estrogen Shapes Dopamine-Dependent Cognitive Processes: Implications for Women's Health
Jacobs, E. G., & D’Esposito, M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6394-10.2011 · Cited by 392 · see citing works
Arnsten, A. F. T., & Pliszka, S. R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.020 · Cited by 383 · see citing works
Arnsten, A. F. T., Raskind, M. A., Taylor, F. B., & Connor, D. F. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2014.10.002 · Cited by 381 · see citing works
O’Donnell, J., Zeppenfeld, D. M., McConnell, E., Pena, S., & Nedergaard, M. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0818-x · Cited by 373 · see citing works
Arnsten, A. F. T. (2009) · CNS Drugs · doi:10.2165/00023210-200923000-00005 · Cited by 371 · see citing works
Arnsten, A. F., & Dudley, A. G. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-2 · Cited by 363 · see citing works
Arnsten, A. F. T., Scahill, L. D., & Findling, R. L. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0098 · Cited by 311 · see citing works
Birnbaum, S., Gobeske, K. T., Auerbach, J., Taylor, J. R., & Arnsten, A. F. T. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00138-9 · Cited by 281 · see citing works
Brennan, A. R., & Arnsten, A. F. T. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.007 · Cited by 267 · see citing works
α-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function
Arnsten, A. F. T., Mathew, R., Ubriani, R., Taylor, J. R., & Li, B.-M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00296-0 · Cited by 245 · see citing works
Self-citationGamo, N. J., Wang, M., & Arnsten, A. F. T. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.06.015 · Cited by 232 · see citing works
Through the looking glass: Differential noradenergic modulation of prefrontal cortical function
Arnsten, A. F. T. (2000) · Neural Plasticity · doi:10.1155/np.2000.133 · Cited by 229 · see citing works
Noradrenergic Suppression of Synaptic Transmission May Influence Cortical Signal-to-Noise Ratio
Hasselmo, M. E., Linster, C., Patil, M., Ma, D., & Cekic, M. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.6.3326 · Cited by 229 · see citing works
ADHD and the Prefrontal Cortex
Arnsten, A. F. T. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.01.018 · Cited by 220 · see citing works
Cools, R., & Arnsten, A. F. T. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01100-8 · Cited by 206 · see citing works
Arnsten, A. F. T. (2000) · Progress in brain research · doi:10.1016/s0079-6123(00)26014-7 · Cited by 194 · see citing works
Franowicz, J. S., Kessler, L. E., Borja, C. M. D., Kobilka, B. K., Limbird, L. E., & Arnsten, A. F. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08771.2002 · Cited by 185 · see citing works
Molecular targets in the treatment of anxiety
KENT, J. M., Mathew, S. J., & Gorman, J. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01672-4 · Cited by 167 · see citing works
Li, B. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00070-6 · Cited by 162 · see citing works
Self-citationDynamic network connectivity: a new form of neuroplasticity
Arnsten, A. F. T., Paspalas, C. D., Gamo, N. J., Yang, Y., & Wang, M. (2010) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.05.003 · Cited by 160 · see citing works
Mao, Z.-M., Arnsten, A. F. T., & Li, B.-M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00139-0 · Cited by 156 · see citing works
Self-citationMattay, V. S., Berman, K. F., Ostrem, J. L., Esposito, G., Van Horn, J. D., Bigelow, L. B., & Weinberger, D. R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-15-04816.1996 · Cited by 151 · see citing works
The beta-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys
Ramos, B. P., Colgan, L., Nou, E., Ovadia, S., Wilson, S. R., & Arnsten, A. F. T. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.022 · Cited by 147 · see citing works
Lacroix, L. P., Dawson, L. A., Hagan, J. J., & Heidbreder, C. A. (2003) · Synapse · doi:10.1002/syn.10288 · Cited by 146 · see citing works
Mcallister, T. W., Flashman, L. A., Sparling, M. B., & Saykin, A. J. (2004) · Brain Injury · doi:10.1080/02699050310001617370 · Cited by 143 · see citing works
Avery, R. A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00111-1 · Cited by 142 · see citing works
Gamo, N. J., & Arnsten, A. F. T. (2011) · Behavioral Neuroscience · doi:10.1037/a0023165 · Cited by 124 · see citing works
Adrenergic targets for the treatment of cognitive deficits in schizophrenia
Arnsten, A. F. T. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1724-3 · Cited by 127 · see citing works
Dorsal anterior cingulate-brainstem ensemble as a reinforcement meta-learner
Silvetti, M., Vassena, E., Abrahamse, E. L., & Verguts, T. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006370 · Cited by 130 · see citing works
Ramos, B. P., Stark, D., Verduzco, L., van Dyck, C. H., & Arnsten, A. F. T. (2006) · Learning & Memory · doi:10.1101/lm.298006 · Cited by 124 · see citing works
Distinct Representations of Cognitive and Motivational Signals in Midbrain Dopamine Neurons
Matsumoto, M., & Takada, M. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.002 · Cited by 117 · see citing works
Carr, D. B., Andrews, G. D., Glen, W. B., & Lavı́n, A. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.141671 · Cited by 119 · see citing works
Franowicz, J. S., & Arnsten, A. F. T. (1998) · Psychopharmacology · doi:10.1007/s002130050533 · Cited by 118 · see citing works
A dopamine gradient controls access to distributed working memory in the large-scale monkey cortex
Froudist‐Walsh, S., Bliss, D. P., Ding, X., Rapan, L., Niu, M., Knoblauch, K., Zilles, K., Kennedy, H., Palomero‐Gallagher, N., & Wang, X. (2021) · Neuron · doi:10.1016/j.neuron.2021.08.024 · Cited by 115 · see citing works
Molecular activity underlying working memoryPreprint
Dash, P. K., Moore, A. N., Kobori, N., & Runyan, J. D. (2007) · Learning & Memory · doi:10.1101/lm.558707 · Cited by 113 · see citing works
Berridge, C. W., & Spencer, R. C. (2016) · Brain Research · doi:10.1016/j.brainres.2015.11.024 · Cited by 112 · see citing works
Noradrenaline and Dopamine Elevations in the Rat Prefrontal Cortex in Spatial Working Memory
Rossetti, Z. L., & Carboni, S. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3038-04.2005 · Cited by 108 · see citing works
Psychostimulants and motivated behavior: Arousal and cognition
Berridge, C. W., & Arnsten, A. F. T. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.11.005 · Cited by 104 · see citing works
Zhang, Z., Matos, S. C., Jego, S., Adamantidis, A., & Séguéla, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066122 · Cited by 105 · see citing works
Cognitive enhancers for the treatment of ADHD
Bidwell, L. C., McClernon, F. J., & Kollins, S. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.05.002 · Cited by 101 · see citing works
The role of prefrontal catecholamines in attention and working memory
Clark, K., & Noudoost, B. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00033 · Cited by 101 · see citing works
Locomotor hyperactivity induced by blockade of prefrontal cortical α2-adrenoceptors in monkeys
Ma, C.-L., Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.004 · Cited by 96 · see citing works
Self-citationSteere, J. C., & Arnsten, A. F. T. (1997) · Behavioral Neuroscience · doi:10.1037//0735-7044.111.5.883 · Cited by 94 · see citing works
Watt, M. J., Weber, M. A., Davies, S. R., & Forster, G. L. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.015 · Cited by 94 · see citing works
Hoffmann, M. W. (2013) · ISRN Neurology · doi:10.1155/2013/892459 · Cited by 90 · see citing works
Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale.
Arnsten, A. F. T., & Jin, L. E. (2012) · Europe PMC (PubMed Central) · Cited by 87 · see citing works
HCN channels in behavior and neurological disease: Too hyper or not active enough?
Lewis, A. S., & Chetkovich, D. M. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.11.007 · Cited by 86 · see citing works
Arnsten, A. F. T., & Jentsch, J. D. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00477-7 · Cited by 85 · see citing works
β2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals
Ramos, B. P., Colgan, L. A., Nou, E., & Arnsten, A. F. T. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.003 · Cited by 82 · see citing works
The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder
Arnsten, A. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.133 · Cited by 80 · see citing works
The effects of arousal on apical amplification and conscious state
Phillips, W. A., Larkum, M. E., Harley, C. W., & Silverstein, S. M. (2016) · Neuroscience of Consciousness · doi:10.1093/nc/niw015 · Cited by 75 · see citing works
Arnsten, A. F. T. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2020.107327 · Cited by 75 · see citing works
“Conversely, infusion of the α2-AR antagonist, yohimbine, into the monkey dlPFC impaired working memory (Li & Mei, 1994), impulse control (Ma, Qi, Peng, & Li, 2003) and regulation of locomotor activity (Ma, Arnsten, & Li, 2005), producing an “ADHD-like” phenotype.”
BackgroundLayer- and area-specific actions of norepinephrine on cortical synaptic transmission
Salgado, H., Treviño, M., & Atzori, M. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.033 · Cited by 71 · see citing works
Molecular mechanisms of working memory
Khan, Z. U., & Muly, E. C. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.12.039 · Cited by 71 · see citing works
Ji, X.-H., Cao, X., Zhang, C.-L., Feng, Z.-J., Zhang, X.-H., Ma, L., & Li, B.-M. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm177 · Cited by 68 · see citing works
Self-citationDegeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease
Song, J., & Kim, J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00065 · Cited by 66 · see citing works
Sallee, F. R., Connor, D. F., & Newcorn, J. H. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0028 · Cited by 64 · see citing works
Ji, X.-H., Ji, J.-Z., Zhang, H., & Li, B.-M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301603 · Cited by 62 · see citing works
Self-citationCognitive Activation by Central Thalamic Stimulation: The Yerkes-Dodson Law Revisited
Mair, R. G., Onos, K. D., & Hembrook‐Short, J. R. (2010) · Dose-Response · doi:10.2203/dose-response.10-017.mair · Cited by 58 · see citing works
Pharmacological and therapeutic directions in ADHD: Specificity in the PFC
Lévy, F. (2008) · Behavioral and Brain Functions · doi:10.1186/1744-9081-4-12 · Cited by 56 · see citing works
Age-related prefrontal alterations during auditory memory
Chao, L. L., & Knight, R. T. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00161-3 · Cited by 55 · see citing works
Sawaguchi, T. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.4.2200 · Cited by 55 · see citing works
Alpha-2 Adrenergic Receptors and Attention-Deficit/Hyperactivity Disorder
Bidwell, L. C., Dew, R. E., & Kollins, S. H. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0136-4 · Cited by 54 · see citing works
Kobori, N., Hu, B., & Dash, P. K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.048 · Cited by 53 · see citing works
Rho, H.-J., Kim, J., & Lee, S. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2018.00047 · Cited by 54 · see citing works
Warneke, W., Klaus, S., Fink, H., Langley‐Evans, S. C., & Voigt, J. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.016 · Cited by 52 · see citing works
Arnsten, A. F. T., & Wang, M. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103617 · Cited by 50 · see citing works
Effects of α-2A adrenergic receptor agonist on time and risk preference in primates
Kim, S., Bobeica, I., Gamo, N. J., Arnsten, A. F. T., & Lee, D. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2520-0 · Cited by 47 · see citing works
Noradrenergic α1-Adrenoceptor Actions in the Primate Dorsolateral Prefrontal Cortex
Datta, D., Yang, S.-T., Galvin, V. C., Solder, J., Luo, F., Morozov, Y. M., Arellano, J., Duque, A., Rakic, P., Arnsten, A. F. T., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2472-18.2019 · Cited by 44 · see citing works
Geffen, G. M., Wright, M. J., Green, H. J., Gillespie, N. A., Smyth, D. C., Evans, D. M., & Geffen, L. B. (1997) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.1997.9.6.743 · Cited by 44 · see citing works
α2-Adrenoceptors are targets for antipsychotic drugs
Brosda, J., Jantschak, F., & Pertz, H. H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3459-8 · Cited by 43 · see citing works
Hou, Y., Wu, C. F., Yang, J., & Guo, T. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.001 · Cited by 40 · see citing works
Potential Noradrenergic Targets for Cognitive Enhancement in Schizophrenia
Friedman, J. I., Stewart, D. G., & Gorman, J. M. (2004) · CNS Spectrums · doi:10.1017/s1092852900009330 · Cited by 40 · see citing works
Clinton, S. M., Sucharski, I. L., & Finlay, J. M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0221-2 · Cited by 37 · see citing works
Rasmussen, T., Fink‐Jensen, A., Sauerberg, P., Swedberg, M. D. B., Thomsen, C., Sheardown, M. J., Jeppesen, L., Calligaro, D. O., DeLapp, N. W., Whitesitt, C. A., et al. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00129-8 · Cited by 37 · see citing works
The Role of Alpha2-Adrenergic Agonists in Attention-Deficit/Hyperactivity Disorder
Sallee, F. R. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.09.2204 · Cited by 36 · see citing works
Dopamine signals and physiological origin of cognitive dysfunction in Parkinson's disease
Matsumoto, M. (2015) · Movement Disorders · doi:10.1002/mds.26177 · Cited by 35 · see citing works
The Role of the Noradrenergic System in Autism Spectrum Disorders, Implications for Treatment
Beversdorf, D. Q. (2020) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2020.100834 · Cited by 35 · see citing works
Tseng, C.-T., Gaulding, S. J., Dancel, C. L., & Thorn, C. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-00976-2 · Cited by 35 · see citing works
Noradrenergic control of error perseveration in medial prefrontal cortex
Caetano, M. S., Jin, L. E., Harenberg, L., Stachenfeld, K., Arnsten, A. F. T., & Laubach, M. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2012.00125 · Cited by 33 · see citing works
Wang, M., Tang, Z.-X., & Li, B.-M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.062 · Cited by 31 · see citing works
Self-citationDopamine Neurotransmission and Atypical Antipsychotics in Prefrontal Cortex: A Critical Review
Masana, M., Santana, N., Artigas, F., & Bortolozzi, A. A. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612805289872 · Cited by 30 · see citing works
Arnsten, A. F. T. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1274-9 · Cited by 31 · see citing works
Abdallah, C., Averill, L., Krystal, J., Southwick, S., & Arnsten, A. (2015) · Behavioral and Brain Sciences · doi:10.1017/s0140525x15001727 · Cited by 397 · see citing works
Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage
Caligiore, D., Silvetti, M., D’Amelio, M., Puglisi‐Allegra, S., & Baldassarre, G. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200276 · Cited by 28 · see citing works
- Authors
- Li, B.-M., & Mei, Z.-T.
- Affiliations
- Chinese Academy of Sciences (CN)
- ORCID
- Li, Bao-Ming
- Venue
- Behavioral and Neural Biology
- Publisher
- Elsevier BV
- Published
- 1994-09
- Volume
- 62
- Issue
- 2
- Pages
- 134-139
- ISSN
- 0163-1047 (ISSN-L)
- OpenAlex
- W2075473160
- Cited by
- 186
- References
- 15
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 3 · 2022: 1 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 7 · 2017: 4 · 2016: 9 · 2015: 13 · 2014: 7 · 2013: 13 · 2012: 8
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Behavioral and Neural Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Keywords
- yohimbine, alpha2-adrenoceptors, dorsolateral prefrontal cortex, delayed response task, spatial working memory, prazosin, propranolol, alpha-blockers, beta-blockers
- MeSH terms
- Animals, Brain Mapping, Female, Macaca mulatta, Orientation, Prazosin, Propranolol, Psychomotor Performance, Reaction Time, Mental Recall, Yohimbine, Prefrontal Cortex, Receptors, Adrenergic, alpha-1, Receptors, Adrenergic, alpha-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review